nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NQO1—Parkinson's disease	0.463	0.677	CbGaD
Doxorubicin—CYP2D6—Parkinson's disease	0.129	0.189	CbGaD
Doxorubicin—ABCB1—Parkinson's disease	0.0921	0.135	CbGaD
Doxorubicin—NOS1—myenteric nerve plexus—Parkinson's disease	0.0103	0.0843	CbGeAlD
Doxorubicin—ABCB8—tongue—Parkinson's disease	0.00467	0.0381	CbGeAlD
Doxorubicin—NOS1—nerve—Parkinson's disease	0.00269	0.0219	CbGeAlD
Doxorubicin—CBR3—embryo—Parkinson's disease	0.00215	0.0176	CbGeAlD
Doxorubicin—NOS1—hindbrain—Parkinson's disease	0.00202	0.0164	CbGeAlD
Doxorubicin—ABCB8—forebrain—Parkinson's disease	0.00198	0.0161	CbGeAlD
Doxorubicin—NDUFS3—hindbrain—Parkinson's disease	0.00198	0.0161	CbGeAlD
Doxorubicin—NDUFS7—forebrain—Parkinson's disease	0.00134	0.0109	CbGeAlD
Doxorubicin—AKR1A1—cardiovascular system—Parkinson's disease	0.00124	0.0101	CbGeAlD
Doxorubicin—NOS1—brainstem—Parkinson's disease	0.00116	0.00942	CbGeAlD
Doxorubicin—NDUFS3—brainstem—Parkinson's disease	0.00113	0.00925	CbGeAlD
Doxorubicin—ABCB8—head—Parkinson's disease	0.00113	0.00924	CbGeAlD
Doxorubicin—NDUFS7—cardiovascular system—Parkinson's disease	0.00113	0.00922	CbGeAlD
Doxorubicin—NOS1—forebrain—Parkinson's disease	0.00111	0.00909	CbGeAlD
Doxorubicin—NDUFS2—forebrain—Parkinson's disease	0.00111	0.00903	CbGeAlD
Doxorubicin—NDUFS3—forebrain—Parkinson's disease	0.00109	0.00892	CbGeAlD
Doxorubicin—CBR3—head—Parkinson's disease	0.00109	0.0089	CbGeAlD
Doxorubicin—ABCB8—nervous system—Parkinson's disease	0.00107	0.00876	CbGeAlD
Doxorubicin—Idarubicin—CYP2D6—Parkinson's disease	0.00107	0.723	CrCbGaD
Doxorubicin—AKR1A1—medulla oblongata—Parkinson's disease	0.00106	0.00867	CbGeAlD
Doxorubicin—DHCR7—forebrain—Parkinson's disease	0.00104	0.00848	CbGeAlD
Doxorubicin—ABCB8—central nervous system—Parkinson's disease	0.00103	0.00844	CbGeAlD
Doxorubicin—CBR3—nervous system—Parkinson's disease	0.00103	0.00843	CbGeAlD
Doxorubicin—ABCB8—cerebellum—Parkinson's disease	0.00101	0.00825	CbGeAlD
Doxorubicin—CBR3—central nervous system—Parkinson's disease	0.000996	0.00812	CbGeAlD
Doxorubicin—CBR3—cerebellum—Parkinson's disease	0.000973	0.00794	CbGeAlD
Doxorubicin—AKR1A1—midbrain—Parkinson's disease	0.000972	0.00792	CbGeAlD
Doxorubicin—YWHAG—forebrain—Parkinson's disease	0.000954	0.00778	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—Parkinson's disease	0.000948	0.00773	CbGeAlD
Doxorubicin—NOS1—cardiovascular system—Parkinson's disease	0.000943	0.00769	CbGeAlD
Doxorubicin—NDUFS2—cardiovascular system—Parkinson's disease	0.000937	0.00764	CbGeAlD
Doxorubicin—NDUFS3—cardiovascular system—Parkinson's disease	0.000925	0.00755	CbGeAlD
Doxorubicin—NDUFS7—midbrain—Parkinson's disease	0.000883	0.0072	CbGeAlD
Doxorubicin—RALBP1—forebrain—Parkinson's disease	0.000862	0.00703	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—Parkinson's disease	0.000861	0.00702	CbGeAlD
Doxorubicin—ABCC6—cardiovascular system—Parkinson's disease	0.000857	0.00699	CbGeAlD
Doxorubicin—NOS3—forebrain—Parkinson's disease	0.000848	0.00691	CbGeAlD
Doxorubicin—AKR1A1—head—Parkinson's disease	0.000842	0.00687	CbGeAlD
Doxorubicin—ABCB8—brain—Parkinson's disease	0.000821	0.0067	CbGeAlD
Doxorubicin—YWHAG—cardiovascular system—Parkinson's disease	0.000807	0.00658	CbGeAlD
Doxorubicin—NOS1—medulla oblongata—Parkinson's disease	0.000806	0.00657	CbGeAlD
Doxorubicin—CBR1—forebrain—Parkinson's disease	0.000804	0.00656	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—Parkinson's disease	0.000801	0.00653	CbGeAlD
Doxorubicin—AKR1A1—nervous system—Parkinson's disease	0.000799	0.00651	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—Parkinson's disease	0.000791	0.00645	CbGeAlD
Doxorubicin—CBR3—brain—Parkinson's disease	0.000791	0.00645	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—Parkinson's disease	0.000769	0.00627	CbGeAlD
Doxorubicin—NDUFS7—head—Parkinson's disease	0.000766	0.00624	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—Parkinson's disease	0.000752	0.00613	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—Parkinson's disease	0.000751	0.00613	CbGeAlD
Doxorubicin—NDUFS2—midbrain—Parkinson's disease	0.000732	0.00597	CbGeAlD
Doxorubicin—RALBP1—cardiovascular system—Parkinson's disease	0.000729	0.00594	CbGeAlD
Doxorubicin—NDUFS7—nervous system—Parkinson's disease	0.000726	0.00592	CbGeAlD
Doxorubicin—NDUFS3—midbrain—Parkinson's disease	0.000723	0.00589	CbGeAlD
Doxorubicin—NOS1—spinal cord—Parkinson's disease	0.000718	0.00586	CbGeAlD
Doxorubicin—NOS3—cardiovascular system—Parkinson's disease	0.000717	0.00584	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—Parkinson's disease	0.000714	0.00582	CbGeAlD
Doxorubicin—AURKA—head—Parkinson's disease	0.000712	0.0058	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—Parkinson's disease	0.000705	0.00575	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—Parkinson's disease	0.000699	0.0057	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—Parkinson's disease	0.000689	0.00562	CbGeAlD
Doxorubicin—DHCR7—midbrain—Parkinson's disease	0.000687	0.0056	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—Parkinson's disease	0.000683	0.00557	CbGeAlD
Doxorubicin—CBR1—cardiovascular system—Parkinson's disease	0.00068	0.00555	CbGeAlD
Doxorubicin—AURKA—nervous system—Parkinson's disease	0.000675	0.0055	CbGeAlD
Doxorubicin—DHCR7—spinal cord—Parkinson's disease	0.00067	0.00546	CbGeAlD
Doxorubicin—AURKA—central nervous system—Parkinson's disease	0.00065	0.0053	CbGeAlD
Doxorubicin—NQO1—forebrain—Parkinson's disease	0.000645	0.00526	CbGeAlD
Doxorubicin—NOS1—head—Parkinson's disease	0.000638	0.00521	CbGeAlD
Doxorubicin—NDUFS2—head—Parkinson's disease	0.000634	0.00517	CbGeAlD
Doxorubicin—YWHAG—midbrain—Parkinson's disease	0.00063	0.00514	CbGeAlD
Doxorubicin—NDUFS3—head—Parkinson's disease	0.000627	0.00511	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—Parkinson's disease	0.000623	0.00508	CbGeAlD
Doxorubicin—YWHAG—spinal cord—Parkinson's disease	0.000615	0.00501	CbGeAlD
Doxorubicin—AKR1A1—brain—Parkinson's disease	0.00061	0.00498	CbGeAlD
Doxorubicin—NOS1—nervous system—Parkinson's disease	0.000605	0.00494	CbGeAlD
Doxorubicin—NDUFS2—nervous system—Parkinson's disease	0.000601	0.0049	CbGeAlD
Doxorubicin—DHCR7—head—Parkinson's disease	0.000595	0.00486	CbGeAlD
Doxorubicin—NDUFS3—nervous system—Parkinson's disease	0.000594	0.00484	CbGeAlD
Doxorubicin—NOS1—central nervous system—Parkinson's disease	0.000583	0.00475	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—Parkinson's disease	0.000581	0.00474	CbGeAlD
Doxorubicin—ABCC6—head—Parkinson's disease	0.00058	0.00473	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—Parkinson's disease	0.000579	0.00472	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—Parkinson's disease	0.000574	0.00468	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—Parkinson's disease	0.000572	0.00466	CbGeAlD
Doxorubicin—NOS1—cerebellum—Parkinson's disease	0.00057	0.00464	CbGeAlD
Doxorubicin—RALBP1—midbrain—Parkinson's disease	0.000569	0.00464	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—Parkinson's disease	0.000566	0.00462	CbGeAlD
Doxorubicin—DHCR7—nervous system—Parkinson's disease	0.000565	0.0046	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—Parkinson's disease	0.000559	0.00456	CbGeAlD
Doxorubicin—RALBP1—spinal cord—Parkinson's disease	0.000555	0.00453	CbGeAlD
Doxorubicin—NDUFS7—brain—Parkinson's disease	0.000555	0.00452	CbGeAlD
Doxorubicin—YWHAG—head—Parkinson's disease	0.000546	0.00445	CbGeAlD
Doxorubicin—NQO1—cardiovascular system—Parkinson's disease	0.000545	0.00444	CbGeAlD
Doxorubicin—DHCR7—central nervous system—Parkinson's disease	0.000543	0.00443	CbGeAlD
Doxorubicin—DHCR7—cerebellum—Parkinson's disease	0.000531	0.00433	CbGeAlD
Doxorubicin—CBR1—midbrain—Parkinson's disease	0.000531	0.00433	CbGeAlD
Doxorubicin—AKR1C3—midbrain—Parkinson's disease	0.000525	0.00428	CbGeAlD
Doxorubicin—POR—medulla oblongata—Parkinson's disease	0.000524	0.00427	CbGeAlD
Doxorubicin—CBR1—spinal cord—Parkinson's disease	0.000518	0.00423	CbGeAlD
Doxorubicin—YWHAG—nervous system—Parkinson's disease	0.000518	0.00422	CbGeAlD
Doxorubicin—AURKA—brain—Parkinson's disease	0.000516	0.00421	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—Parkinson's disease	0.000512	0.00417	CbGeAlD
Doxorubicin—YWHAG—central nervous system—Parkinson's disease	0.000499	0.00407	CbGeAlD
Doxorubicin—RALBP1—head—Parkinson's disease	0.000493	0.00402	CbGeAlD
Doxorubicin—YWHAG—cerebellum—Parkinson's disease	0.000487	0.00397	CbGeAlD
Doxorubicin—NOS3—head—Parkinson's disease	0.000485	0.00396	CbGeAlD
Doxorubicin—POR—midbrain—Parkinson's disease	0.000479	0.00391	CbGeAlD
Doxorubicin—RALBP1—nervous system—Parkinson's disease	0.000468	0.00381	CbGeAlD
Doxorubicin—POR—spinal cord—Parkinson's disease	0.000467	0.00381	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—Parkinson's disease	0.000466	0.0038	CbGeAlD
Doxorubicin—NOS1—brain—Parkinson's disease	0.000463	0.00377	CbGeAlD
Doxorubicin—CBR1—head—Parkinson's disease	0.000461	0.00376	CbGeAlD
Doxorubicin—NOS3—nervous system—Parkinson's disease	0.00046	0.00375	CbGeAlD
Doxorubicin—NDUFS2—brain—Parkinson's disease	0.00046	0.00375	CbGeAlD
Doxorubicin—NDUFS3—brain—Parkinson's disease	0.000454	0.0037	CbGeAlD
Doxorubicin—RALBP1—central nervous system—Parkinson's disease	0.00045	0.00367	CbGeAlD
Doxorubicin—NOS3—central nervous system—Parkinson's disease	0.000443	0.00361	CbGeAlD
Doxorubicin—RALBP1—cerebellum—Parkinson's disease	0.00044	0.00359	CbGeAlD
Doxorubicin—CBR1—nervous system—Parkinson's disease	0.000437	0.00356	CbGeAlD
Doxorubicin—DHCR7—brain—Parkinson's disease	0.000431	0.00352	CbGeAlD
Doxorubicin—NQO1—midbrain—Parkinson's disease	0.000426	0.00347	CbGeAlD
Doxorubicin—CBR1—central nervous system—Parkinson's disease	0.00042	0.00343	CbGeAlD
Doxorubicin—CYP2D6—hindbrain—Parkinson's disease	0.000418	0.00341	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—Parkinson's disease	0.000416	0.00339	CbGeAlD
Doxorubicin—NQO1—spinal cord—Parkinson's disease	0.000415	0.00339	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—Parkinson's disease	0.000411	0.277	CrCbGaD
Doxorubicin—CBR1—cerebellum—Parkinson's disease	0.000411	0.00335	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—Parkinson's disease	0.000406	0.00331	CbGeAlD
Doxorubicin—YWHAG—brain—Parkinson's disease	0.000396	0.00323	CbGeAlD
Doxorubicin—CYP1B1—cardiovascular system—Parkinson's disease	0.000383	0.00312	CbGeAlD
Doxorubicin—ABCC10—midbrain—Parkinson's disease	0.00038	0.0031	CbGeAlD
Doxorubicin—ABCC10—spinal cord—Parkinson's disease	0.000371	0.00302	CbGeAlD
Doxorubicin—POR—cerebellum—Parkinson's disease	0.000371	0.00302	CbGeAlD
Doxorubicin—NQO1—head—Parkinson's disease	0.000369	0.00301	CbGeAlD
Doxorubicin—RALBP1—brain—Parkinson's disease	0.000358	0.00292	CbGeAlD
Doxorubicin—NOS3—brain—Parkinson's disease	0.000352	0.00287	CbGeAlD
Doxorubicin—NQO1—nervous system—Parkinson's disease	0.00035	0.00285	CbGeAlD
Doxorubicin—NQO1—central nervous system—Parkinson's disease	0.000337	0.00275	CbGeAlD
Doxorubicin—CBR1—brain—Parkinson's disease	0.000334	0.00272	CbGeAlD
Doxorubicin—ABCC3—head—Parkinson's disease	0.000331	0.0027	CbGeAlD
Doxorubicin—AKR1C3—brain—Parkinson's disease	0.00033	0.00269	CbGeAlD
Doxorubicin—NQO1—cerebellum—Parkinson's disease	0.000329	0.00268	CbGeAlD
Doxorubicin—ABCC3—nervous system—Parkinson's disease	0.000314	0.00256	CbGeAlD
Doxorubicin—ABCC3—central nervous system—Parkinson's disease	0.000302	0.00247	CbGeAlD
Doxorubicin—POR—brain—Parkinson's disease	0.000301	0.00245	CbGeAlD
Doxorubicin—ABCC10—cerebellum—Parkinson's disease	0.000294	0.0024	CbGeAlD
Doxorubicin—NQO1—brain—Parkinson's disease	0.000267	0.00218	CbGeAlD
Doxorubicin—CYP2B6—cardiovascular system—Parkinson's disease	0.000263	0.00214	CbGeAlD
Doxorubicin—CYP1B1—head—Parkinson's disease	0.000259	0.00211	CbGeAlD
Doxorubicin—CYP1B1—nervous system—Parkinson's disease	0.000246	0.002	CbGeAlD
Doxorubicin—ABCG2—medulla oblongata—Parkinson's disease	0.000244	0.00199	CbGeAlD
Doxorubicin—ABCC3—brain—Parkinson's disease	0.00024	0.00196	CbGeAlD
Doxorubicin—CYP2D6—brainstem—Parkinson's disease	0.000239	0.00195	CbGeAlD
Doxorubicin—ABCC10—brain—Parkinson's disease	0.000239	0.00195	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—Parkinson's disease	0.000237	0.00193	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—Parkinson's disease	0.000231	0.00189	CbGeAlD
Doxorubicin—CYP2D6—forebrain—Parkinson's disease	0.000231	0.00188	CbGeAlD
Doxorubicin—ABCG2—midbrain—Parkinson's disease	0.000223	0.00181	CbGeAlD
Doxorubicin—ABCG2—spinal cord—Parkinson's disease	0.000217	0.00177	CbGeAlD
Doxorubicin—ABCC1—cerebellum—Parkinson's disease	0.000208	0.0017	CbGeAlD
Doxorubicin—ABCB1—embryo—Parkinson's disease	0.000188	0.00153	CbGeAlD
Doxorubicin—CYP1B1—brain—Parkinson's disease	0.000188	0.00153	CbGeAlD
Doxorubicin—CYP2B6—head—Parkinson's disease	0.000178	0.00145	CbGeAlD
Doxorubicin—ABCG2—cerebellum—Parkinson's disease	0.000172	0.0014	CbGeAlD
Doxorubicin—ABCC1—brain—Parkinson's disease	0.000169	0.00138	CbGeAlD
Doxorubicin—CYP2B6—nervous system—Parkinson's disease	0.000169	0.00138	CbGeAlD
Doxorubicin—ABCB1—forebrain—Parkinson's disease	0.000166	0.00136	CbGeAlD
Doxorubicin—CYP2B6—central nervous system—Parkinson's disease	0.000163	0.00133	CbGeAlD
Doxorubicin—ABCB1—cardiovascular system—Parkinson's disease	0.000141	0.00115	CbGeAlD
Doxorubicin—ABCG2—brain—Parkinson's disease	0.00014	0.00114	CbGeAlD
Doxorubicin—CYP2D6—head—Parkinson's disease	0.000132	0.00108	CbGeAlD
Doxorubicin—CYP2B6—brain—Parkinson's disease	0.000129	0.00105	CbGeAlD
Doxorubicin—CYP3A4—nervous system—Parkinson's disease	0.000127	0.00104	CbGeAlD
Doxorubicin—CYP2D6—nervous system—Parkinson's disease	0.000125	0.00102	CbGeAlD
Doxorubicin—CYP3A4—central nervous system—Parkinson's disease	0.000123	0.001	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—Parkinson's disease	0.000121	0.000985	CbGeAlD
Doxorubicin—ABCB1—medulla oblongata—Parkinson's disease	0.00012	0.000979	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—Parkinson's disease	0.000118	0.000962	CbGeAlD
Doxorubicin—ABCB1—midbrain—Parkinson's disease	0.00011	0.000895	CbGeAlD
Doxorubicin—ABCB1—spinal cord—Parkinson's disease	0.000107	0.000873	CbGeAlD
Doxorubicin—CYP2D6—brain—Parkinson's disease	9.59e-05	0.000782	CbGeAlD
Doxorubicin—ABCB1—head—Parkinson's disease	9.52e-05	0.000776	CbGeAlD
Doxorubicin—ABCB1—nervous system—Parkinson's disease	9.02e-05	0.000736	CbGeAlD
Doxorubicin—ABCB1—central nervous system—Parkinson's disease	8.69e-05	0.000708	CbGeAlD
Doxorubicin—ABCB1—cerebellum—Parkinson's disease	8.49e-05	0.000692	CbGeAlD
Doxorubicin—ABCB1—brain—Parkinson's disease	6.9e-05	0.000562	CbGeAlD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	1.43e-05	7.47e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CTGF—Parkinson's disease	1.41e-05	7.37e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GSTM1—Parkinson's disease	1.41e-05	7.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—COMT—Parkinson's disease	1.4e-05	7.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADRBK1—Parkinson's disease	1.4e-05	7.3e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.4e-05	7.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GSTP1—Parkinson's disease	1.39e-05	7.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MAOA—Parkinson's disease	1.39e-05	7.26e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTHFR—Parkinson's disease	1.39e-05	7.25e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—INS—Parkinson's disease	1.39e-05	7.23e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—HMOX1—Parkinson's disease	1.38e-05	7.18e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NDUFB11—Parkinson's disease	1.37e-05	7.16e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP2E1—Parkinson's disease	1.37e-05	7.16e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.37e-05	7.12e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—OMD—Parkinson's disease	1.37e-05	7.12e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NQO1—Parkinson's disease	1.36e-05	7.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DRD2—Parkinson's disease	1.35e-05	7.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR7—Parkinson's disease	1.35e-05	7.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MTHFR—Parkinson's disease	1.35e-05	7.06e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GPX1—Parkinson's disease	1.35e-05	7.05e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLA2G6—Parkinson's disease	1.35e-05	7.03e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF2—Parkinson's disease	1.34e-05	7.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTHFR—Parkinson's disease	1.34e-05	7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.34e-05	6.98e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TH—Parkinson's disease	1.34e-05	6.98e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MAOB—Parkinson's disease	1.33e-05	6.96e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCB1—Parkinson's disease	1.32e-05	6.89e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.32e-05	6.89e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP2E1—Parkinson's disease	1.32e-05	6.86e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GCH1—Parkinson's disease	1.31e-05	6.83e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NQO1—Parkinson's disease	1.3e-05	6.79e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1R—Parkinson's disease	1.3e-05	6.78e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.29e-05	6.75e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—APOE—Parkinson's disease	1.29e-05	6.75e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYCS—Parkinson's disease	1.28e-05	6.7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EDN1—Parkinson's disease	1.28e-05	6.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GSTM1—Parkinson's disease	1.28e-05	6.69e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TH—Parkinson's disease	1.28e-05	6.69e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—INS—Parkinson's disease	1.27e-05	6.64e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APOE—Parkinson's disease	1.26e-05	6.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—APOE—Parkinson's disease	1.25e-05	6.51e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—MTHFR—Parkinson's disease	1.25e-05	6.5e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.23e-05	6.44e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYCS—Parkinson's disease	1.23e-05	6.42e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GPX1—Parkinson's disease	1.23e-05	6.4e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ADRBK1—Parkinson's disease	1.22e-05	6.35e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HSPA1A—Parkinson's disease	1.21e-05	6.3e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CASP3—Parkinson's disease	1.2e-05	6.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NGF—Parkinson's disease	1.18e-05	6.15e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—FBP1—Parkinson's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GBA—Parkinson's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—DBH—Parkinson's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—DDC—Parkinson's disease	1.16e-05	6.06e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—APOE—Parkinson's disease	1.16e-05	6.05e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—COMT—Parkinson's disease	1.14e-05	5.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF2—Parkinson's disease	1.14e-05	5.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTHFR—Parkinson's disease	1.13e-05	5.91e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTP1—Parkinson's disease	1.13e-05	5.9e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MAOA—Parkinson's disease	1.13e-05	5.89e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP2D6—Parkinson's disease	1.13e-05	5.88e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HTR2A—Parkinson's disease	1.12e-05	5.86e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—HMOX1—Parkinson's disease	1.12e-05	5.82e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CTGF—Parkinson's disease	1.11e-05	5.77e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—INS—Parkinson's disease	1.11e-05	5.77e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK8—Parkinson's disease	1.1e-05	5.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GBA—Parkinson's disease	1.1e-05	5.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.1e-05	5.74e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DBH—Parkinson's disease	1.1e-05	5.74e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1R—Parkinson's disease	1.1e-05	5.73e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTA4—Parkinson's disease	1.1e-05	5.72e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP2D6—Parkinson's disease	1.09e-05	5.69e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—COMT—Parkinson's disease	1.09e-05	5.69e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTP1—Parkinson's disease	1.08e-05	5.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EDN1—Parkinson's disease	1.08e-05	5.66e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MAOA—Parkinson's disease	1.08e-05	5.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—INS—Parkinson's disease	1.08e-05	5.61e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCB1—Parkinson's disease	1.07e-05	5.59e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CTGF—Parkinson's disease	1.07e-05	5.58e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—HMOX1—Parkinson's disease	1.07e-05	5.58e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—INS—Parkinson's disease	1.07e-05	5.56e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—APOE—Parkinson's disease	1.05e-05	5.5e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	1.05e-05	5.46e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APOE—Parkinson's disease	1.04e-05	5.45e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTM1—Parkinson's disease	1.04e-05	5.42e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP2E1—Parkinson's disease	1.03e-05	5.38e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ABCB1—Parkinson's disease	1.03e-05	5.36e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	1.02e-05	5.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NQO1—Parkinson's disease	1.02e-05	5.32e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TH—Parkinson's disease	1e-05	5.24e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTM1—Parkinson's disease	9.97e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP2E1—Parkinson's disease	9.97e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NGF—Parkinson's disease	9.97e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GPX1—Parkinson's disease	9.96e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP2D6—Parkinson's disease	9.92e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—INS—Parkinson's disease	9.91e-06	5.17e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	9.88e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NQO1—Parkinson's disease	9.86e-06	5.14e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	9.8e-06	5.11e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MAOB—Parkinson's disease	9.78e-06	5.1e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CTGF—Parkinson's disease	9.73e-06	5.08e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TH—Parkinson's disease	9.72e-06	5.07e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYCS—Parkinson's disease	9.64e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	9.61e-06	5.01e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX1—Parkinson's disease	9.55e-06	4.98e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ND3—Parkinson's disease	9.49e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MCCC1—Parkinson's disease	9.49e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—Parkinson's disease	9.49e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYCS—Parkinson's disease	9.33e-06	4.87e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—Parkinson's disease	9.19e-06	4.79e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP2E1—Parkinson's disease	9.07e-06	4.73e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—INS—Parkinson's disease	9.01e-06	4.7e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NQO1—Parkinson's disease	8.97e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—OMD—Parkinson's disease	8.92e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TALDO1—Parkinson's disease	8.92e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—INS—Parkinson's disease	8.92e-06	4.65e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TH—Parkinson's disease	8.84e-06	4.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—Parkinson's disease	8.82e-06	4.6e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—Parkinson's disease	8.81e-06	4.6e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—DDC—Parkinson's disease	8.57e-06	4.47e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—Parkinson's disease	8.56e-06	4.46e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—COMT—Parkinson's disease	8.54e-06	4.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	8.52e-06	4.44e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTP1—Parkinson's disease	8.5e-06	4.43e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYCS—Parkinson's disease	8.49e-06	4.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MAOA—Parkinson's disease	8.48e-06	4.42e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	8.46e-06	4.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—HMOX1—Parkinson's disease	8.38e-06	4.37e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—COMT—Parkinson's disease	8.26e-06	4.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—Parkinson's disease	8.24e-06	4.3e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTP1—Parkinson's disease	8.22e-06	4.29e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MAOA—Parkinson's disease	8.2e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—Parkinson's disease	8.2e-06	4.28e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—HMOX1—Parkinson's disease	8.11e-06	4.23e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTA4—Parkinson's disease	8.09e-06	4.22e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DDC—Parkinson's disease	8.08e-06	4.21e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GCH1—Parkinson's disease	8.07e-06	4.21e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—Parkinson's disease	8.05e-06	4.2e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—Parkinson's disease	8.03e-06	4.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTM1—Parkinson's disease	7.81e-06	4.08e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—Parkinson's disease	7.78e-06	4.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—Parkinson's disease	7.67e-06	4e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTA4—Parkinson's disease	7.63e-06	3.98e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	7.61e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTM1—Parkinson's disease	7.56e-06	3.94e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—INS—Parkinson's disease	7.53e-06	3.93e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—COMT—Parkinson's disease	7.52e-06	3.92e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX1—Parkinson's disease	7.48e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTP1—Parkinson's disease	7.48e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MAOA—Parkinson's disease	7.46e-06	3.89e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—HMOX1—Parkinson's disease	7.38e-06	3.85e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INS—Parkinson's disease	7.31e-06	3.81e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLA2G6—Parkinson's disease	7.29e-06	3.8e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	7.27e-06	3.79e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX1—Parkinson's disease	7.24e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MAOB—Parkinson's disease	7.21e-06	3.76e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—FBP1—Parkinson's disease	7.19e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DBH—Parkinson's disease	7.19e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GBA—Parkinson's disease	7.19e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CTGF—Parkinson's disease	7.14e-06	3.72e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—Parkinson's disease	7.08e-06	3.69e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—Parkinson's disease	7.03e-06	3.67e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INS—Parkinson's disease	7.01e-06	3.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—Parkinson's disease	6.9e-06	3.6e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTM1—Parkinson's disease	6.87e-06	3.59e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	6.87e-06	3.58e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MAOB—Parkinson's disease	6.8e-06	3.55e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—Parkinson's disease	6.68e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	6.65e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—Parkinson's disease	6.64e-06	3.46e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX1—Parkinson's disease	6.58e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NQO1—Parkinson's disease	6.57e-06	3.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—INS—Parkinson's disease	6.56e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TH—Parkinson's disease	6.48e-06	3.38e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—Parkinson's disease	6.43e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYCS—Parkinson's disease	6.22e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—Parkinson's disease	6.22e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK8—Parkinson's disease	6.1e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—Parkinson's disease	6.07e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—Parkinson's disease	6.05e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—Parkinson's disease	5.66e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—Parkinson's disease	5.61e-06	2.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—Parkinson's disease	5.56e-06	2.9e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—COMT—Parkinson's disease	5.51e-06	2.87e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—Parkinson's disease	5.49e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTP1—Parkinson's disease	5.48e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MAOA—Parkinson's disease	5.47e-06	2.85e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—Parkinson's disease	5.41e-06	2.82e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2D6—Parkinson's disease	5.36e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—Parkinson's disease	5.31e-06	2.77e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DDC—Parkinson's disease	5.28e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CTGF—Parkinson's disease	5.26e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—Parkinson's disease	5.19e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—Parkinson's disease	5.16e-06	2.69e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—Parkinson's disease	5.04e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	4.99e-06	2.6e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CTGF—Parkinson's disease	4.96e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2E1—Parkinson's disease	4.9e-06	2.56e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NQO1—Parkinson's disease	4.85e-06	2.53e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—Parkinson's disease	4.83e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—Parkinson's disease	4.83e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TH—Parkinson's disease	4.78e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—Parkinson's disease	4.7e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	4.62e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYCS—Parkinson's disease	4.59e-06	2.39e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.57e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TH—Parkinson's disease	4.5e-06	2.35e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.49e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—Parkinson's disease	4.45e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.44e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.32e-06	2.26e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—Parkinson's disease	4.15e-06	2.16e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—COMT—Parkinson's disease	4.06e-06	2.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTP1—Parkinson's disease	4.04e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MAOA—Parkinson's disease	4.03e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—Parkinson's disease	3.99e-06	2.08e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—Parkinson's disease	3.9e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—COMT—Parkinson's disease	3.83e-06	2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTP1—Parkinson's disease	3.81e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MAOA—Parkinson's disease	3.8e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—Parkinson's disease	3.76e-06	1.96e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—Parkinson's disease	3.72e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.61e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—Parkinson's disease	3.56e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—Parkinson's disease	3.54e-06	1.85e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.5e-06	1.83e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.35e-06	1.75e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.3e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—Parkinson's disease	3.29e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—Parkinson's disease	3.28e-06	1.71e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.24e-06	1.69e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.09e-06	1.61e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—Parkinson's disease	3.06e-06	1.6e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.02e-06	1.58e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.99e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TH—Parkinson's disease	2.94e-06	1.54e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—Parkinson's disease	2.88e-06	1.5e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—Parkinson's disease	2.86e-06	1.49e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.83e-06	1.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—Parkinson's disease	2.61e-06	1.36e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COMT—Parkinson's disease	2.5e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.49e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.49e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—Parkinson's disease	2.46e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.46e-06	1.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.36e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.29e-06	1.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.19e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.02e-06	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—Parkinson's disease	1.88e-06	9.83e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—Parkinson's disease	1.61e-06	8.4e-06	CbGpPWpGaD
